Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 06-2011 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -40 | 32 | 30 | -19 | -20 |
| Other Working Capital | 141 | -29 | -529 | 455 | -327 |
| Other Operating Activity | 1,702 | -1,794 | -1,992 | -3,074 | -2,454 |
| Operating Cash Flow | $1,803 | $-1,791 | $-2,491 | $-2,638 | $-2,801 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -3 | -9 | -31 | -182 |
| Sale Of Investment | N/A | 973 | 1,024 | N/A | N/A |
| Purchase Sale Intangibles | -4 | -16 | -144 | N/A | N/A |
| Other Investing Activity | -6,282 | 15 | 30 | 327 | -1,643 |
| Investing Cash Flow | $-6,300 | $969 | $901 | $296 | $-1,825 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,922 | 0 | 2,501 | 2,650 | N/A |
| Other Financing Activity | -412 | 0 | -151 | -150 | -3 |
| Financing Cash Flow | $6,510 | $0 | $2,350 | $2,500 | $-3 |
| Beginning Cash Position | 834 | 1,656 | 896 | 1,334 | 5,963 |
| End Cash Position | 2,847 | 834 | 1,656 | 1,492 | 1,334 |
| Net Cash Flow | $2,013 | $-822 | $760 | $158 | $-4,629 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,803 | -1,791 | -2,491 | -2,638 | -2,801 |
| Capital Expenditure | -18 | -19 | -153 | -31 | -182 |
| Free Cash Flow | 1,785 | -1,810 | -2,644 | -2,669 | -2,983 |